{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:03:42Z","timestamp":1790175822750,"version":"4.1.0"},"reference-count":47,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/13696998.2025.2496070","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T05:04:39Z","timestamp":1745471079000},"page":"665-673","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Economic evaluation of PCV21 in vaccine-na\u00efve adults aged 19\u201364 years with underlying medical conditions in the United States"],"prefix":"10.1080","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4997-3121","authenticated-orcid":false,"given":"Zinan","family":"Yi","sequence":"first","affiliation":[{"name":"Biostatistics & Research Decision Sciences, Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9993-8036","authenticated-orcid":false,"given":"Elamin H.","family":"Elbasha","sequence":"additional","affiliation":[{"name":"Biostatistics & Research Decision Sciences, Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4519-2857","authenticated-orcid":false,"given":"Kwame","family":"Owusu-Edusei","sequence":"additional","affiliation":[{"name":"Biostatistics & Research Decision Sciences, Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7203a1"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.824788"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00540-21"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00937-20"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094580"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0001-8"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30310-4"},{"key":"e_1_3_4_9_1","unstructured":"Centers for Disease Control and Prevention. Chapter 11: pneumococcal manual for the surveillance of vaccine-preventable diseases; 2020 [cited 2023 May]. Available from: https:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt11-pneumo.html."},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.05.061"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052116"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060273"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy800"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-206780"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7104a1"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7336a3"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7401a1"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01067-1"},{"key":"e_1_3_4_19_1","volume-title":"CPI for all urban consumers (CPI-U): medical care in U.S. city average, all urban consumers, not seasonally adjusted","author":"Bureau of Labor Statistics","year":"2023","unstructured":"Bureau of Labor Statistics. CPI for all urban consumers (CPI-U): medical care in U.S. city average, all urban consumers, not seasonally adjusted. Bureau of Labor Statistics; 2023 [cited 2024 January 23]. Available from: https:\/\/www.bls.gov\/cpi\/."},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540150055031"},{"key":"e_1_3_4_21_1","unstructured":"United States Census Bureau. Annual estimates of the resident population by single year of age and sex for the United States for year 2022; 2023 [cited 2024 March 6]. Available from: https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2020s-national-detail.html."},{"key":"e_1_3_4_22_1","unstructured":"Hung M-C Srivastav A Lu P-J et\u00a0al. Vaccination coverage among adults in the United States National Health Interview Survey 2021; 2022. Available from: https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/pubs-resources\/vaccination-coverage-adults-2021.html."},{"key":"e_1_3_4_23_1","volume-title":"1998\u20132021 serotype data for invasive pneumococcal disease cases by age group from active bacterial core surveillance","author":"Centers for Disease Control and Prevention","year":"2023","unstructured":"Centers for Disease Control and Prevention. 1998\u20132021 serotype data for invasive pneumococcal disease cases by age group from active bacterial core surveillance. Atlanta, GA Active Bacterial Core Surveillance; 2023."},{"key":"e_1_3_4_24_1","volume-title":"ABCs bact facts interactive data dashboard | CDC","author":"Centers for Disease Control and Prevention","year":"2024","unstructured":"Centers for Disease Control and Prevention. ABCs bact facts interactive data dashboard | CDC. Atlanta, GA: Centers for Disease Control and Prevention; 2024."},{"key":"e_1_3_4_25_1","volume-title":"Economic assessment of PCV20 for adults vaccinated with PCV13: presented at ACIP, October 19, 2022","author":"Stoecker C.","year":"2022","unstructured":"Stoecker C. Economic assessment of PCV20 for adults vaccinated with PCV13: presented at ACIP, October 19, 2022. Atlanta, GA: Centers for Disease Control and Prevention; 2022."},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.087"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae316"},{"key":"e_1_3_4_28_1","unstructured":"Centers for Disease Control and Prevention. CDC vaccine price list; 2024 [cited 2024 July 20]. Available from: https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/index.html."},{"key":"e_1_3_4_29_1","unstructured":"Pfizer Inc. Statutory Price Disclosure For Connecticut Prescribers. 2024 [cited 2024 March 6]. Available from: https:\/\/cdn.pfizer.com\/pfizercom\/products\/ctprescribers\/PREVNAR20CTPriceDisclosureShortForm01112024.pdf."},{"key":"e_1_3_4_30_1","unstructured":"Micromedex Solutions. Capvaxive. Red book online; 2024. https:\/\/www.micromedexsolutions.com\/home\/dispa tch."},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2006.03.008"},{"key":"e_1_3_4_32_1","volume-title":"Economic assessment of PCV15 & PCV20: presentation to the ACIP June 25, 2021","author":"Stoecker C.","year":"2021","unstructured":"Stoecker C. Economic assessment of PCV15 & PCV20: presentation to the ACIP June 25, 2021. Atlanta, GA: Centers for Disease Control and Prevention; 2021."},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10935-015-0394-3"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.09.049"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1542520"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00325-2015"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408544"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.10.024"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.09.019"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.09.049"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2018.12.007"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.01.049"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003326"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03277-3"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.06.007"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.04.002"},{"key":"e_1_3_4_47_1","volume-title":"Economic assessment of PCV21 in U.S. adults","author":"Stoecker C.","year":"2024","unstructured":"Stoecker C. Economic assessment of PCV21 in U.S. adults. Atlanta, GA: Centers for Disease Control and Prevention; 2024."},{"key":"e_1_3_4_48_1","volume-title":"Advisory committee on immunization","author":"Leidner A.","year":"2024","unstructured":"Leidner A. Summary of three economic analyses on the use of 21-valent pneumococcal conjugate vaccine (PCV21) among adults in the United States. Atlanta, GA: Advisory committee on immunization; 2024."}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2025.2496070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:43:30Z","timestamp":1766400210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2025.2496070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/13696998.2025.2496070"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2025.2496070","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}